Gastrointestinal telangiectasia: a study by EGD, colonoscopy, and capsule endoscopy in 75 patients

Background:The distribution of lesions in the gastrointestinal tract in patients with sporadic telangiectasia is at present unknown.

Patients and methods:75 patients with sporadic telangiectasia underwent esophagogastroduodenoscopy (EGD), capsule endoscopy, and colonoscopy. Endoscopic diagnosis of telangiectasia and gastrointestinal bleeding were required for enrollment in the study. Hemorrhagic diathesis, co-morbidity, number of blood transfusions, and subsequent management were also noted.

Results:35 of the patients presented with gastroduodenal vascular lesions, 51 with small-bowel lesions, and 28 with colonic lesions. 67 % of patients in whom EGD found telangiectasia also presented small-bowel vascular lesions at capsule endoscopy and 43 % colonic lesions at colonoscopy. 54 % percent of patients with positive colonoscopy also presented gastroduodenal lesions and 48 % small-bowel lesions. Patients with known duodenal lesions were more likely to have small-bowel lesions at capsule endoscopy (odds ratio [OR] 10.19, 95 % CI 2.1 - 49.33, P = 0.003). Patients with associated diseases, such as liver cirrhosis, chronic renal failure, or heart valvulopathy, presented more severe disease requiring blood transfusions (OR 6.37, 95 % CI 1.39 - 29.2, P = 0.015). The number of blood transfusions correlated with the number of sites affected (R = 0.35, P = 0.002). The detection of new lesions at capsule endoscopy allowed new treatment in 46 % of patients. Mean follow-up was 18 months.

Conclusions:Sporadic telangiectasia is a multifocal disease potentially involving the whole digestive tract. Patients with duodenal telangiectasia show a higher risk of jejunal or ileal lesions. Capsule endoscopy is a useful diagnostic tool for the detection of such small-bowel vascular lesions, indicating a more specific prognosis and treatment strategy.

References

• 1 Shovlin C L. Molecular defects in rare bleeding disorders: hereditary hemorrhagic telangiectasia.  Thromb Haemost. 1997;  78 145-150
• 2 Marchuk D A. Genetic abnormalities in hereditary hemorrhagic telangiectasia.  Curr Opin Hematol. 1998;  5 332-338
• 3 Gostout C J, Viggiano T R, Ahlquist D A. et al . The clinical and endoscopic spectrum of watermelon stomach.  J Clin Gastroenterol. 1992;  15 256-263
• 4 Spahr L, Villeneuve J P, Dufresne M P. et al . Gastric antral vascular ectasia in cirrhotic patients: absence of relation with portal hypertension.  Gut. 1999;  44 739-742
• 5 Liberski S M, McGarrity T J, Hartle R J. et al . The watermelon stomach: long term outcome in patients with Nd:YAG laser therapy for watermelon stomach.  Gastrointest Endosc. 1990;  36 399-402
• 6 Sargeant I R, Loizou L A, Rampton D. et al . Laser ablation of upper gastrointestinal vascular ectasias. Long term results.  Gut. 1993;  34 470-475
• 7 Stotzer P O, Willen R, Kilander A F. Watermelon stomach: not only an antral disease.  Gastrointet Endosc. 2002;  55 897-900
• 8 Bowmick B K. Watermelon stomach treated with oral cortocosteroid.  J R Soc Med. 1993;  86 52
• 9 McCormick P A, Oii H, Crosbie O. Tranexamic acid for severe bleeding antral vascular ectasia in cirrhosis.  Gut. 1998;  42 750-752
• 10 Nardone G, Rocco A, Balzano T. et al . The efficacy of octreotide therapy in chronic bleeding due to vascular abnormalities of the gastrointestinal tract.  Aliment Pharmacol Ther. 1999;  13 1429-1436
• 11 Van Custem E, Rutgeerts P, van Trappen G. Treatment of bleeding gastrointestinal vascular malformations with oestrogen progesterone.  Lancet. 1990;  13 953-955
• 12 Tran A, Villeneuve J P, Bilodeau M. et al . Treatment of chronic bleeding from gastric antral vascular ectasia (GAVE) with oestrogen progesterone in cirrhotic patients: an open pilot study.  Am J Gastroenterol. 1999;  94 2909-2911
• 13 Barbara G, De Giorgio R, Selvioli B. et al . Unsuccesful octreotide treatment of the watermelon stomach.  J Clin Gastroenterol. 1998;  26 345-346
• 14 Rose J DR. Endoscopic injection of alcohol for bleeding for gastroduodenal vascular anomalies.  Br Med J. 1987;  295 93-94
• 15 Cugia L, Carta M, Dore M P. et al . The watermelon stomach: successful treatment by monopolar electrocoagulation and endoscopic injection of polidocanol.  J Clin Gastroenterol. 2000;  31 93-94
• 16 Binmoeller K F, Katon R M. Bipolar electrocoagulation for watermelon stomach.  Gastrointest Endosc. 1990;  36 399-402
• 17 Petrini J J, Johnston J. Heater probe for antral vascular ectasia.  Gastrointest Endosc. 1989;  35 324-328
• 18 Wahab P J, Mulder C J, den Hartog G. et al . Argon plasma coagulation in flexible gastrointestinal endoscopy; pilot experiences.  Endoscopy. 1997;  29 176-181
• 19 Yusoff I, Brennan F, Ormonde D. et al . Argon plasma coagulation for the treatment of watermelon stomach.  Endoscopy. 2002;  34 407-410
• 20 Mathou N G, Lovat L B, Thorpe S M. et al . Nd:YAG laser induces long-term remission in transfusion-dependent patients with watermelon stomach.  Lasers Med Sci. 2004;  18 213-218
• 21 Polese L, Angriman I, Pagano D. et al . Laser therapy and surgical treatment in transfusion-dependent patients with upper-gastrointestinal vascular ectasia.  Lasers Med Sci. 2006;  21 140-146
• 22 Proctor D D, Henderson K J, Dziura J D. et al . Enteroscopic evaluation of the gastrointestinal tract in symptomatic patients with hereditary hemorrhagic telangiectasia.  J Clin Gastroenterol. 2005;  39 115-119
• 23 Ingrosso M, Sabbà C, Pisani A. et al . Evidence of small-bowel involvement in hereditary hemorrhagic telangiectasia: a capsule-endoscopic study.  Endoscopy. 2004;  36 1074-1079
• 24 Tang S J, Zanati S, Kandel G. et al . Gastric intestinal vascular ectasia syndrome: findings on capsule endoscopy.  Endoscopy. 2005;  37 1244-1247
• 25 Shovlin C L, Guttmacher A E, Buscarini E. et al . Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome).  Am J Med Genet. 2000;  91 66-67
• 26 Burak K W, Lee S S, Beck P L. Portal hypertensive gastropathy and gastric antral vascular estasia (GAVE) sindrome.  Gut. 2001;  49 866-872
• 27 Sturniolo G C, Di Leo V, Vettorato M G. et al . Small bowel exploration by wireless capsule endoscopy: results from 314 procedures.  Am J Med. 2006;  119 341-347
• 28 Pennazio M. Small-intestinal pathology on capsule endoscopy: spectrum of vascular lesions.  Endoscopy. 2005;  37 864-869
• 29 Leighton J A, Triester S L, Sharma V K. Capsule endoscopy: a meta-analysis for use with obscure gastrointestinal bleeding and Crohn’s disease.  Gastrointest Endoscopy Clin North Am. 2006;  16 229-250
• 30 Delvaux M, Fassler I, Gay G. Capsule endoscopy followed by push-pull enteroscopy (double balloon enteroscopy): diagnostic yield in patients with suspected intestinal disease.  Endoscopy. 2005;  37 (Suppl 1) A72
• 31 Nakamura M, Niwa Y, Ohmiya N. et al . Preliminary comparison of capsule endoscopy and double-balloon enteroscopy in patients with suspected small-bowel bleeding.  Endoscopy. 2006;  38 59-66
• 32 Karagiannis S, Goulas S, Kosmadakis G. et al . Wireless capsule endoscopy in the investigation of patients with chronic renal falure and obscure gastrointestinal bleeding (preliminary data).  World J Gastroenterol. 2006;  12 5182-5185
• 33 De Palma G D, Rega M, Masone S. et al . Mucosal abnormalities of the small bowel in patients with cirrhosis and portal hypertension: a capsule endoscopy study.  Gastrointest Endosc. 2005;  62 529-534